On July 14, Definium Therapeutics rose 5.13% in regular trading, trading at $45.845 USD/share, with Turnover of $23.838 million.
Within the Pharmacy sector where Definium Therapeutics belongs, the overall sector showed broad weakness. Among individual stocks, Eli Lilly down 2.56%, Johnson & Johnson down 1.86%, Merck down 2.87%, Pfizer down 1.02%, AstraZeneca down 2.12%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)